Life Sciences Funding in View: 2025 Outlook

Top 3 Emerging Markets Uptick in activity despite the drop in number of deals

Austin

Houston

Minneapolis

$800

60

$450

50

$400

40

45

$400

$700

$350

35

50

40

$350

$600

$300

30

35

40

$300

$500

$250

25

30

$250

$400

30

25

$200

20

$200

20

$300

$150

15

20

$150

15

$200

$100

10

$100

Capital Invested ($Millions)

Capital Invested ($Millions)

Capital Invested ($Millions)

10

10

$100

$50

5

$50

5

$155.3

$217.3

$373.8

$230.5

$285.4

$237.7

$349.1

$167.7

$209.8

$186.4

$264.9

$157.6

$309.0

$394.4

$707.0

$0

0

$0

0

$0

0

2020 2021 2022 2023 2024

2020 2021 2022 2023 2024

2020 2021 2022 2023 2024

Deal Volume Number of Deals (RHS)

Deal Volume Number of Deals (RHS)

Deal Volume Number of Deals (RHS)

15 / CUSHMAN & WAKEFIELD

LIFE SCIENCES JANUARY 2025